Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadoquatrane vs macrocyclic GBCAs for CNS contrast-enhanced MRI (Phase 3, crossover)
CTR20232190Phase 3Completed
- Sponsor
- ---
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gadoquatrane in acute neurological injury, sponsored by ---. Started Jul 2023; status: completed.
02
Drugs
gadoquatrane
03
Conditions
acute neurological injury
Beyond the preview
Go deeper on CTR20232190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232190.